Please add info@sitcancer.org to your safe senders list. |
Support SITC Membership Meetings About SITC www.sitcancer.org |
January 2016 – In this Issue Society Updates | Global Impact | Education & Events | Membership | Publications| Careers A Message from the PresidentDear Colleagues, It is hard to believe that we are now into 2016. New this year, SITC has expanded its membership to include nurses, physician extenders, pharmacists, patients, and patient advocates. We welcome them to contribute their perspectives to the Society and join the record number of members we have today. You can help SITC expand its impact and continue on its upward trajectory by becoming an official member of the Society's growing network of leaders in the field. As many of you know, U.S. President Barack Obama announced during his final State of the Union Address a “moonshot” to cure cancer, which entails doubling the progress in cancer research and treatment over the next five years. To launch this initiative, current Vice President Joe Biden is focusing on greater allocation of resources and increased multi-stakeholder collaborative efforts. The Society for Immunotherapy of Cancer (SITC) recognizes that collaboration is key to advancing the science and application of cancer immunotherapy—and cancer care as a whole. I am proud to inform you that SITC leaders are at the forefront of this effort, working with our NCI and FDA colleagues, to promote the role of immunotherapy in this important national initiative. As a core value of the Society, SITC brings together stakeholders spanning a wide breadth of specialties and professional roles from across the globe to engage in scientific exchange, networking, and education that lead to progress in the field. We are in a strong position to contribute to the moonshot initiative and we will count on your support at this historic time in the development of the field. Together, our members and collaborative partners can one day make the word “cure” a reality for cancer patients everywhere. And, on behalf of the Society, I invite you to join us along the way. Best regards, Howard L. Kaufman, MD, FACS Society UpdatesSITC 2016 Cancer Immunotherapy Fellowship Award Submission Portal Now Open In concert with the Society’s mission to improve cancer patient outcomes through the development and application of cancer immunotherapy, SITC is presenting to student members several one-year fellowship opportunities, which were made possible through the generosity of AstraZeneca, EMD Serono, and Genentech. Applications will be accepted through Monday, March 7, 2016. Learn more and apply here. Global ImpactBreast-Gynecological International Cancer Conference Sparks Cancer Immunotherapy Discussion in Egypt Presented by the Breast-Gynecological International Cancer Society in collaboration with the Society for Immunotherapy of Cancer The 8th Breast-Gynecological International Cancer Conference (BGICC) provided a platform for scientific exchange and outlined the status of problems relating to breast and gynecological cancers. The most recent international trends and initiatives for treatment were discussed, including immunotherapy for the first time ever in Egypt. To learn more, download the report from Secretary General of the BGICC, Prof. Hesham Elghazaly (Ain Shams University), here. Education & EventsImmuno-Oncology 360º February 2-3, 2016 • The New York Academy of Medicine • New York, New York Presented by The Conference Forum in collaboration with the Society for Immunotherapy of Cancer Immuno-Oncology 360° combines business and clinical development strategies with scientific updates to prepare the market for accelerating immuno-oncology clinical trials. SITC President, Howard L. Kaufman, MD, FACS (Rutgers Cancer Institute of New Jersey), will participate as a speaker and panelist alongside other leaders in the field. Learn more and register here. II Translational Forum on Cancer Immunotherapy (FIT-Cancer II) March 11-12, 2016 • Seville, Spain Presented by the Spanish Group for Immuno-Biological Therapies in Cancer (GÉTICA) in collaboration with the Society for Immunotherapy of Cancer This program, held in Spanish, aims to guide oncologists in integrating immunotherapy into the therapeutic strategy for cancer patients. Learn more and register here. Third Immunotherapy of Cancer Conference (ITOC-3) March 21-23, 2016 Presented by the Cancer Drug Development Forum (CDDF) in collaboration with the Society for Immunotherapy of Cancer ITOC-3 will provide a forum for discussion of early clinical drug development and address the unique challenges of drug development. As such, the conference attracts a multi-stakeholder attendance, connecting preclinical and clinical scientists, clinicians, healthcare professionals, academia, and other stakeholders who are involved in the development of novel anticancer agents. Learn more and register here. Immunotherapy Biomarkers 2016: Overcoming the Barriers Cosponsored with the National Cancer Institute Friday, April 1, 2016 • 8 a.m. – 5 p.m. "Cancer immunotherapy biomarkers are an area of critical need in the field," states SITC Vice President and SITC Immune Biomarkers Task Force Chair, Lisa H. Butterfield, PhD. "They provide insight into mechanism of action, and can help predict who should be enrolled into clinical trials, or at least who is likely to benefit. At this meeting, the SITC Immune Biomarkers Task Force Working Groups will present their summaries of the state of the field, identify hurdles, highlight new opportunities and make recommendations, all in a one day program." Learn more and register here. Cancer Immunotherapy 101 is Headed for Milwaukee, Wisconsin Thursday, April 7, 2016 • 5 – 8:45 p.m. Part of the Advances in Cancer ImmunotherapyTM series, this introductory, CME- and CE-certified program will provide clinical oncologists, nurses, pharmacists, and the entire team involved in treating cancer patients with a greater understanding of cancer immunotherapies, their therapeutic effectiveness, and the appropriate selection and management of patients. Learn more and register here. Can't make it to Milwaukee? More dates and locations are available! Save the Dates for SITC 2016 – November 9-13, 2016 Gaylord National Hotel & Convention Center • National Harbor, Maryland Mark your calendars for SITC's 31st
Annual Meeting & Associated Programs! Known as the premier
destination for scientific exchange, education and networking in the
cancer immunotherapy field, this is the conference you don't want to miss. Learn more. Membership Makes a Difference
|
Society for Immunotherapy of Cancer (SITC) © 2016 Society for Immunotherapy of Cancer Join us on: If you do not wish to be included in our mailing list, please forward this message to info@sitcancer.org with the word "Remove" in the subject line. Please add info@sitcancer.org to your safe senders list. |